The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE Inc., an innovative biotech company developing novel point-of-care assays to help with ...
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE.
ADVAITE announced the company's high complexity CLIA laboratory operating out of Chicago, IL has been authorized to offer Yale University's SalivaDirect? test.
Diagnostic testing kit, ADVAITE RAPCOV, has ability to provide results in 15-30 minutes from a drop of fingertip blood and offers a solution for mass screening.